Literature DB >> 10812198

Glutamine transport in brain mitochondria.

E Kvamme1, B Roberg, I A Torgner.   

Abstract

Gln is transported into rat brain synaptic and non-synaptic mitochondria by a protein catalyzed process. The uptake is significantly higher in synaptic than in non-synaptic mitochondria. The transport is inhibited by the amino acids Glu, Asn and Asp, and by the TCA cycle intermediates succinate, malate and 2-OG. The inhibition by 2-OG is counteracted by AOA and is therefore assumed to be due to transamination of 2-OG, whereby Glu is formed. This presumes that Glu also binds to an inhibitory site on the matrix face of the inner membrane. The transport is complex and cannot be explained by the simple uniport mechanism which has been proposed for renal (Schoolwerth and LaNoue, 1985), and liver mitochondria (Soboll et al., 1991). Thus, Gln transport is stimulated by respiration and by the proton electrochemical gradient. Since it is indicated that both the neutral Gln zwitterion and the Gln anion are transported, there are probably different uptake mechanisms, but not necessarily different carriers. Gln may be transported by an electroneutral mechanism as a proton compensated anion, as well as electrophoretically as a zwitterion with a proton, and probably also by diffusion as a zwitterion. The properties of the brain mitochondrial Gln uptake mechanisms are also not identical with those of a purified renal Gln transporter. It is possible that the Gln transport is controlled by more than one protein, which may be situated on distinct species in a heterogeneous mitochondrial population. Since Gln is assumed to participate in energy production as well as in the synthesis of nucleic acid components and proteins in brain mitochondria, the control of Gln uptake in these organelles may be important.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812198     DOI: 10.1016/s0197-0186(00)00016-4

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

Review 1.  Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain.

Authors:  E Kvamme; B Roberg; I A Torgner
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Roles of glutamine synthetase inhibition in epilepsy.

Authors:  Tore Eid; Kevin Behar; Ronnie Dhaher; Argyle V Bumanglag; Tih-Shih W Lee
Journal:  Neurochem Res       Date:  2012-04-10       Impact factor: 3.996

3.  Zwitterion formation in gas-phase cyclodextrin complexes.

Authors:  Seonghee Ahn; Xin Cong; Carlito B Lebrilla; Scott Gronert
Journal:  J Am Soc Mass Spectrom       Date:  2005-02       Impact factor: 3.109

4.  Current Status of Our Understanding for Brain Integrated Functions and its Energetics.

Authors:  Anjani Kumar Tiwari; Anupriya Adhikari; Lokesh Chandra Mishra; Abhishek Srivastava
Journal:  Neurochem Res       Date:  2022-06-11       Impact factor: 4.414

Review 5.  Roles of changes in active glutamine transport in brain edema development during hepatic encephalopathy: an emerging concept.

Authors:  Magdalena Zielińska; Mariusz Popek; Jan Albrecht
Journal:  Neurochem Res       Date:  2013-09-26       Impact factor: 3.996

6.  Glutamine Improves Oxidative Stress through the Wnt3a/β-Catenin Signaling Pathway in Alzheimer's Disease In Vitro and In Vivo.

Authors:  Yuan Wang; Qiang Wang; Jie Li; Gang Lu; Zhibin Liu
Journal:  Biomed Res Int       Date:  2019-04-16       Impact factor: 3.411

7.  Effects of Aging and Tocotrienol-Rich Fraction Supplementation on Brain Arginine Metabolism in Rats.

Authors:  Musalmah Mazlan; Hamizah Shahirah Hamezah; Nursiati Mohd Taridi; Yu Jing; Ping Liu; Hu Zhang; Wan Zurinah Wan Ngah; Hanafi Ahmad Damanhuri
Journal:  Oxid Med Cell Longev       Date:  2017-11-19       Impact factor: 6.543

8.  The Antagonistic Effect of Glutamine on Zearalenone-Induced Apoptosis via PI3K/Akt Signaling Pathway in IPEC-J2 Cells.

Authors:  Tianhu Wang; Jingjing Wang; Tong Zhang; Aixin Gu; Jianping Li; Anshan Shan
Journal:  Toxins (Basel)       Date:  2021-12-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.